Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xin-Fu-Ke-Min
- Development stage
- Unknown
- Lead developer
- GenMont Biotech
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Xin-Fu-Ke-Min is a multi-strain probiotic dietary supplement developed by GenMont Biotech, a Taiwan-based company specializing in functional probiotics and prebiotics. The product is formulated as an oral capsule or sachet containing a proprietary blend of *Lactobacillus* species, including *L. paracasei*, *L. paracasei 33*, *L. casei*, *L. fermentum*, *L. acidophilus*, and *L. reuteri*. It also incorporates prebiotics such as xylooligosaccharide and beta-glucan to support the growth and activity of beneficial gut bacteria. Xin-Fu-Ke-Min is marketed for the maintenance of gut health and gastrointestinal wellness by modulating the intestinal microbiota and promoting a balanced digestive environment. It is intended for use by infants, children, and adults as a functional food supplement.
- Brand names
- Xin-Fu-Ke-MinGenMont Xin-Fu-Ke-Min probiotic capsules
- Other names
- GenMont Xin-Fu-Ke-Min
Beyond the preview
Go deeper on Xin-Fu-Ke-Min.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xin-Fu-Ke-Min.